FSA & HSA Eligible
Microdose: More ways to get started
Noom Microdose GLP-1Rx Program helps you lose weight and get healthy.
- Personalized: Microdose Compounded Semaglutide and Tirzepatide offerings
- Limited Time Offer: Plans start at $491 and include medication
- Friendly: A gentle start to weight loss
Paired with behavior change and coaching–for results that last.
1 Initial 3 week subscription and 4 weeks of medication from $49 plus tax and $179 per month plus tax for 12 week subscription thereafter. Final pricing depends on program selection. Includes medication (if prescribed) and full program access. Cancel anytime.
Why Noom Microdose?
Noom Microdose GLP-1Rx Program is the easy way to start on GLP-1s, providing a smaller dose compared to our standard GLP‑1 plan. It’s designed to be easy on your body and to kickstart your weight-loss goals.
Plans start at just $491
Affordable care that provides real results, including meds, clinical visits, and ongoing support
Lose up to 17 pounds in 60 days2
Lose weight comfortably with dosing tailored to your body and pace.
Behavior change and coaching
Get access to Noom GLP-1 Companion for extra support
A low dose doesn’t mean low weight loss
We found our members lost up to 9 pounds in just 30 days.2
How it Works
1
Take a brief intake survey
Share your health history and weight-loss goals and receive your clinical plan.
2
Connect with an expert clinician
A clinician will quickly evaluate your results and provide a prescription all online, if clinically appropriate.
3
Start losing weight with your customized Microdose plan
Get medication shipped, if eligible, and begin your journey with the lowest effective dose that delivers results.3
4
Ongoing care and medication
Receive continuous monitoring and adjustments, with unlimited access to your clinician and medication refills, where clinically appropriate.
Success Stories
Real members, real results with Noom Microdose
“Noom provided me with the medication which I could not get through Medicare. I have learned the tricks to better eating and life in general.”
32 pounds lost, 15 weeks on Noom
Steve M.
“My medication has removed my cravings for sugar. I am down 16 pounds.”
16 pounds lost, 4 weeks on Noom
Laura
Frequently Asked Questions
How does microdosing a GLP-1 work?
Noom’s Microdose Program uses lower doses of medication designed by our Chief Medical Officer to lose weight, reduce side effects, preserve muscle mass, and support sustainable weight management.
How is Noom Microdose GLP-1Rx Program different from Noom’s other GLP-1 programs?
The Microdose Program utilizes lower doses of medication. It comes with the same comprehensive Noom program and clinical care and support as our other Med programs.
What kind of support comes with Noom Microdose GLP-1Rx Program?
You’ll have access to our clinical team, receive dose optimization guidance, coaching support, and a community of members on similar journeys.
How long does it take to see results?
Most members begin losing weight within the first month. The gradual approach is designed to drive sustainable results that are easier to maintain long-term.
Which Microdose medication options are available?
The Noom Microdose GLP-1Rx Program currently includes Microdose Semaglutide and Microdose Tirzepatide options. Medication availability, dosing, and eligibility are determined by licensed clinicians based on medical history and treatment goals.
How is Noom Microdose GLP-1Rx Program different from Noom’s other GLP-1 programs?
The Microdose Program utilizes lower doses of medication and currently offers Microdose Semaglutide and Microdose Tirzepatide options. It includes the same comprehensive Noom program, clinical care, and support available through our other Med programs.
1Initial 3 week subscription and 4 weeks of medication from $49 plus tax and $179 per month plus tax for 12 week subscription thereafter. Final pricing depends on program selection. Compounded semaglutide available through Noom-GLP1Rx is produced in an FDA-registered facility but has not been reviewed by the FDA for safety, efficacy, or quality. Be sure to discuss any concerns with your Noom Med clinician before starting treatment. No affiliation with Novo Nordisk, Inc., the only US source of FDA-approved semaglutide. No affiliation with Eli Lilly and Company, the only US source of FDA-approved tirzepatide. Not available in all 50 states. New pricing for new accounts only effective as of July 27, 2026.
2 Results obtained from a study of 3,562 Noom users self-reported data with at least 27 bmi. Average expected weight loss for those who followed the titration protocol was 5.8 lbs.
3 Not all medications are available for home delivery. Availability of home delivery will depend on your insurance or cash pay status. If your clinician feels compounded medications are clinically appropriate for you, any compounded medications are not approved by the FDA or reviewed for quality, safety or efficacy. Novo Nordisk, Inc. is the only United States company with FDA-approved products containing semaglutide, identified under the trade names Rybelsus®, Ozempic® and Wegovy®. Lilly USA LLC is the only United States company with FDA-approved products containing tirzepatide identified under the trade names Zepbound® and Mounjaro®